Orthofix Medical Inc OFIX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Did Orthofix Medical Inc. Insiders Breach their Fiduciary Duties to Shareholders?
-
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Orthofix Medical Inc. (NASDAQ: OFIX)
-
Orthofix to Participate in Upcoming Investor Conferences
-
Orthofix Expands Pediatric Limb Reconstruction Portfolio with New FITBONE™ Innovation at POSNA 2026 Annual Meeting
-
Halper Sadeh LLC Encourages Orthofix Medical Inc. Shareholders to Contact the Firm to Discuss Their Rights
-
Orthofix Reports First Quarter 2026 Results Highlighting Steady Execution Following Spine Commercial Channel Actions; Reaffirms Full-Year 2026 Financial Guidance
-
Orthofix Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Orthofix Medical, Inc. - OFIX
-
Orthofix to Report First Quarter 2026 Financial Results
Trading Information
- Previous Close Price
- $9.69
- Day Range
- $9.64–10.03
- 52-Week Range
- $9.13–16.99
- Bid/Ask
- $9.07 / $11.98
- Shares Outstanding
- 40.42M
- Market Cap
- $398.96M
- Volume/Avg
- 513,428 / 346,905
Key Statistics
- Price/Earnings (Normalized)
- 23.62
- Price/Sales
- 0.48
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 1,605
- Website
- https://www.orthofix.com
Valuation
|
Metric
|
OFIX
|
|---|---|
Price/Earnings (Normalized) | 23.62 |
Price/Book Value | 0.92 |
Price/Sales | 0.48 |
Price/Cash Flow | 7.26 |
Price/Earnings
OFIX
Financial Strength
|
Metric
|
OFIX
|
|---|---|
Quick Ratio | 1.60 |
Current Ratio | 2.87 |
Interest Coverage | −2.19 |
Quick Ratio
OFIX
Profitability
|
Metric
|
OFIX
|
|---|---|
Return on Assets (Normalized) | −4.25% |
Return on Equity (Normalized) | −8.01% |
Return on Invested Capital (Normalized) | −3.23% |
Return on Assets
OFIX
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Rtrxfjcc | Dtmbrc | $159B | |||
| Stryker Corp
SYK
| Vtyyzvbt | Xfmyv | $120B | |||
| Medtronic PLC
MDT
| Pynqdrbk | Gcjqprf | $105B | |||
| Boston Scientific Corp
BSX
| Tvfvxgr | Zyktgp | $73B | |||
| Edwards Lifesciences Corp
EW
| Wsdhhzwq | Sptdx | $50B | |||
| DexCom Inc
DXCM
| Cdgztwfvf | Wcbvzwh | $30B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| Qmppbrssq | Frt | $30B | |||
| Koninklijke Philips NV ADR
PHG
| Qnqm | Njbhw | $25B | |||
| Steris PLC
STE
| Dqnmdzbzz | Xbnbsb | $21B | |||
| Zimmer Biomet Holdings Inc
ZBH
| Pmxwkcgzj | Ltdll | $17B |
United States